High sensitivity of PD-L1 analysis from pleural effusion in nonsmall cell lung cancer

Background: Programmed cell death protein 1 (PD-1)/programmed cell death protein ligand 1 (PD-L1) immune checkpoint inhibitors have been approved for monotherapy of metastatic nonsmall cell lung cancer (mNSCLC) depending on tumour cells' PD-L1 expression. Pleural effusion is common in mNSCLC. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagmeyer, Lars, Schäfer, Stephan, Engels, Marianne, Pietzke-Calcagnile, Anja, Treml, Marcel, Herkenrath, Simon-Dominik, Heldwein, Matthias, Hekmat, Khosro, Matthes, Sandhya, Scheel, Andreas, Wolf, Jürgen, Büttner, Reinhard, Randerath, Winfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983225/
https://www.ncbi.nlm.nih.gov/pubmed/33778051
http://dx.doi.org/10.1183/23120541.00787-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983225/
https://www.ncbi.nlm.nih.gov/pubmed/33778051
http://dx.doi.org/10.1183/23120541.00787-2020

Ejemplares similares